marginally significantP = 0.05
[ 26 ] showed that treatment of C57BL6 mice with a GCGR-Ab at a weekly dose of 5 mg/kg for 4 weeks increased islet delta cell number by ∼35% in association with marginally significant (P = 0.05) delta cell proliferation.